This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal

James W. Maas, MD; Jan A. Fawcett, MD; Haroutune Dekirmenjian, PhD

Arch Gen Psychiatry. 1972;26(3):252-262.

Abstract
The relationship between therapeutic response and the urinary excretion of norepinephrine and its metabolites by depressed patients before and during treatment with imipramine or desimipramine has been examined. Those patients who excreted the lesser quantities of 3-methoxy-4-hydroxyphenylglycol (MHPG) prior to drug treatment had the best response to medication. Similar relationships were not found for metanephrine, normetanephrine, or vanillymandelic acid (VMA). Those patients who responded best excreted greater quantities of normetanephrine and MHPG during drug treament, relative to the predrug period, and those patients who responded least well had a decrement in the excretion of these two metabolities. There were significant decrements in the quantities of VMA and metanephrine excreted in urine during drug treatment but these changes were unrelated to the therapeutic response. The theoretical and practical implications of these findings are discussed.

Author Affiliations
Chicago

From the Illinois State Psychiatric Institute, Chicago.

Footnotes
Accepted for publication Sept 8, 1971.

A portion of this paper was read before the American Psychiatric Association, Washington, DC, May, 1971.

Reprint requests to Illinois State Psychiatric Institute, 1601 W Taylor St, Chicago 60612 (Dr. Maas).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Retinoid-Mediated Regulation of Mood: Possible Cellular Mechanisms
O'Reilly et al.
Exp. Biol. Med. 2008;233:251-258.
ABSTRACT | FULL TEXT  

Elevated Brain Serotonin Turnover in Patients With Depression: Effect of Genotype and Therapy
Barton et al.
Arch Gen Psychiatry 2008;65:38-46.
ABSTRACT | FULL TEXT  

Reduced Brain Norepinephrine and Dopamine Release in Treatment-Refractory Depressive Illness: Evidence in Support of the Catecholamine Hypothesis of Mood Disorders
Lambert et al.
Arch Gen Psychiatry 2000;57:787-793.
ABSTRACT | FULL TEXT  

Endogenous inhibitors of monoamine oxidase present in human cerebrospinal fluid
Becker et al.
Science 1983;221:476-478.
ABSTRACT  

Alteration of Norepinephrine Metabolism With Desipramine and Zimelidine in Depressed Patients
Linnoila et al.
Arch Gen Psychiatry 1982;39:1025-1028.
ABSTRACT  

High Correlation of Norepinephrine and Its Major Metabolite Excretion Rates
Linnoila et al.
Arch Gen Psychiatry 1982;39:521-523.
ABSTRACT  

Antipsychotic Effects of Pimozide in Schizophrenia: Treatment Response Prediction With Acute Dextroamphetamine Response
van Kammen et al.
Arch Gen Psychiatry 1982;39:261-266.
ABSTRACT  

Specific and sensitive radioimmunoassay for 3-methoxy-4-hydroxyphenylethyleneglycol (MOPEG)
Keeton et al.
Science 1981;211:586-588.
ABSTRACT  

3-Methoxy-4-hydroxyphenethyleneglycol production by human brain in vivo
Maas et al.
Science 1979;205:1025-1027.
ABSTRACT  

State Anxiety, Physical Activity, and Urinary 3-Methoxy-4-Hydroxyphenethylene Glycol Excretion
Sweeney et al.
Arch Gen Psychiatry 1978;35:1418-1423.
ABSTRACT  

Toward a Biochemical Classification of Depressive Disorders: I. Differences in Urinary Excretion of MHPG and Other Catecholamine Metabolites in Clinically Defined Subtypes of Depressions
Schildkraut et al.
Arch Gen Psychiatry 1978;35:1427-1433.
ABSTRACT  

Primary Affective Disorder, Clinical State Change, and MHPG Excretion: A Longitudinal Study
Pickar et al.
Arch Gen Psychiatry 1978;35:1378-1383.
ABSTRACT  

Imipramine and Desipramine in Plasma and Spinal Fluid: Relationship to Clinical Response and Serotonin Metabolism
Muscettola et al.
Arch Gen Psychiatry 1978;35:621-625.
ABSTRACT  

Catecholamine Metabolism in Anorexia Nervosa
Halmi et al.
Arch Gen Psychiatry 1978;35:458-460.
ABSTRACT  

CNS Monoamine Metabolism in Bipolar Affective Disorder: Evaluation Using a Peripheral Decarboxylase Inhibitor
Garfinkel et al.
Arch Gen Psychiatry 1977;34:735-739.
ABSTRACT  

Reduced Growth Hormone Responses to Amphetamine in "Endogenous" Depressive Patients: Studies in Normal, "Reactive" and "Endogenous" Depressive, Schizophrenic, and Chronic Alcoholic Subjects
Langer et al.
Arch Gen Psychiatry 1976;33:1471-1475.
ABSTRACT  

Prediction of Tricyclic Antidepressant Response: A Critical Review
Bielski and Friedel
Arch Gen Psychiatry 1976;33:1479-1489.
ABSTRACT  

Electroencephalographic Sleep Diagnosis of Primary Depression
Coble et al.
Arch Gen Psychiatry 1976;33:1124-1127.
ABSTRACT  

Biogenic Amines and Depression: Biochemical and Pharmacological Separation of Two Types of Depression
Maas and Maas
Arch Gen Psychiatry 1975;32:1357-1361.
ABSTRACT  

The Basis for Amine Hypotheses in Affective Disorders: A Critical Evaluation
Baldessarini
Arch Gen Psychiatry 1975;32:1087-1093.
ABSTRACT  

Overview of Recent Research in Depression: Integration of Ten Conceptual Models Into a Comprehensive Clinical Frame
Akiskal and McKinney
Arch Gen Psychiatry 1975;32:285-305.
ABSTRACT  

Antidepressant Response to Tricyclics and Urinary MHPG in Unipolar Patients: Clinical Response to Imipramine or Amitriptyline
Beckmann and Goodwin
Arch Gen Psychiatry 1975;32:17-21.
ABSTRACT  

Brain Biogenic Amine Depletion and Mood
Mendels and Frazer
Arch Gen Psychiatry 1974;30:447-451.
ABSTRACT  

Norepinephrine Uptake into Cerebral Cortical Synaptosomes after One Fight or Electroconvulsive Shock
Welch et al.
Science 1974;183:220-221.
ABSTRACT  

Behavior of Free-Ranging Macaques after Intraventricular 6-Hydroxydopamine
Redmond et al.
Science 1973;181:1256-1258.
ABSTRACT  

Relation of Exercise to MHPG Excretion in Normal Subjects
Goode et al.
Arch Gen Psychiatry 1973;29:391-396.
ABSTRACT  

MHPG Excretion in Depressive Disorders: Relation to Clinical Subtypes and Desynchronized Sleep
Schildkraut et al.
Science 1973;181:762-764.
ABSTRACT